Marea Therapeutics Announces Oral Presentation Related to Acromegaly Program at ENDO 2025

Candid Therapeutics Advances Portfolio of Novel T-Cell Engagers into Five Autoimmune Diseases for Clinical Evaluation

Casma Therapeutics Nominates CSM-101 as a Development Candidate for the Treatment of Rare and Common Forms of Parkinson’s Disease

Septerna to Present at Jefferies Global Healthcare Conference

Flare Therapeutics to Participate in Jefferies Global Healthcare Conference